September 14, 2012 — IBA Molecular North America Inc., a manufacturer and distributor of PET imaging tracers, has announced the introduction of its Centers for Innovation, two unique facilities designed for advanced radiopharmaceutical contract development and manufacturing. The centers are located in Totowa and Somerset, N.J.  Complementing these sites are IBA Molecular's production capabilities for isotopes such as I-124, F-18, Zr-89 and in the future, Cu-64 and Y-86. The centers are expected to play an important role in the development of a new generation of disease-specific tracers and companion theragnostics.

The primary site is a state-of-the-art radiopharmaceutical facility in Totowa, N.J. This fully equipped 8,500-square-foot research and development center is staffed by a team of accomplished professionals, including radiochemists, nuclear pharmacists, QC chemists and cyclotron engineers. The staff has expertise in radio-labeling, product development and industrialization of new tracers, technology transfer and GMP production of doses for clinical trials.  These attributes make the site an ideal destination for collaborative projects. With both large (mAbs, proteins, etc.) and small molecule radio-labeling expertise, the center can develop processes to support almost any new tracer, including those that utilize isotopes such as F-18, I-124 and Zr-89.  All of these endeavors are geared toward supporting human clinical trials of novel tracers.

These GMP-validated sites provide a broad range of capabilities, including:

  • Compounding of I-124 capsules for clinical use
  • Producing the highest purity I-124 available under a DMF for this radioisotope
  • Production of novel tracers integral to preclinical translational research
  • Scalable infrastructure and investigational products for all phases of clinical studies
  • Production of novel tracers integral to hybrid-probe development
  • A supporting resource or "think-tank" for development and industrialization
  • Scalable infrastructure capable of supporting solid targetry for research isotope production including Cu-64, Y-86 and other isotopes


"The molecular imaging industry needs an accelerant to drive innovation and new products. Our specialized knowledge and outstanding facilities in radiopharmaceutical development and manufacturing are at the disposal of our partners and will undoubtedly assist in bringing new products to the market faster," said Lee Karras, president of IBA Molecular North America Inc. "These Centers for Innovation will provide researchers, pharma and biotech companies with access to our unmatched expertise in small and large molecules, as well as our proven track record with the development of novel tracers.  Standing alongside these centers is IBA Molecular's global commercial network of nuclear pharmacies, which will be paramount to the successful launch of any new, commercialized tracer."

IBA Molecular has development and manufacturing partnerships with a number of pharmaceutical firms, including Wilex, Aposense and Piramal Imaging, as well as ongoing research collaborations with noted medical institutions throughout the U.S. and Europe.

For more information: www.iba-molecular.com

Related Content

News | Nuclear Imaging

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

Time November 22, 2021
arrow
Videos | Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
News | Digital Pathology

November 15, 2021 — Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and ...

Time November 15, 2021
arrow
News | Molecular Imaging

October 29, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time October 29, 2021
arrow
News | Radiation Therapy

October 19, 2021 — RAD Technology Medical Systems (RAD) announced that it will be exhibiting at the 2021 American ...

Time October 19, 2021
arrow
News | PET Imaging

October 19, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 19, 2021
arrow
News | PET Imaging

October 18, 2021 — PSMA (prostate-specific membrane antigen) PET/CT is more accurate than conventional CT in the ...

Time October 18, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

Time September 20, 2021
arrow
Subscribe Now